title: Beating A Cancer Death Sentence.
abstract: A melanoma survivor describes his arduous-and costly-path to successful treatment and hope.
authors.affiliation: Jonathan Friedlaender (jfriedla@temple.edu) is an emeritus professor of biological anthropology at Temple University, in Philadelphia, Pennsylvania. He is a patient representative for the Food and Drug Administration, in Silver Spring, Maryland. He has held positions at Harvard University, the University of Wisconsin-Madison, and the National Science Foundation.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Friedlaender
mesh_terms: D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008545:Melanoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D033262:Narration; D009361:Neoplasm Invasiveness / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000628:therapy; D009367:Neoplasm Staging; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017741:Survivors / Q000523:psychology*
keywords: Cost of Health Care; Ethical Issues; Pharmaceuticals